News
The GIST treatment landscape has shifted in recent years due to the emergence of new therapies, many of which patients should ...
The FDA approved the Dako Omnis panel to identify patients with colorectal cancer with mismatch repair deficiency.
The FDA declined approval of Darzalex Faspro for newly diagnosed, transplant-ineligible multiple myeloma in its current form.
CURE spoke with an expert about the needs of children in families living with cancer during back-to-school season.
Through cancer treatment, loss, as well as many life changes, I found healing in simple moments of community and laughter ...
Being diagnosed with a disease like prostate cancer is a very impactful life event, making it vital to have people you love ...
Kimberly (Cary) Demirhan, a registered nurse and assistant director of Education Programs at the Association of Cancer Care Centers (ACCC), sat down for an interview with CURE to discuss the need for ...
Watch a webinar as experts on tenosynovial giant cell tumor (TGCT) share an overview of TGCT and a simple summary of the MOTION study.
CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in ...
The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung ...
Study finds anti-nausea drug aprepitant boosts distant disease-free and breast cancer-specific survival in early-stage triple ...
I share how my friendship with advocate Amy Byer Shainman helped me navigate hereditary cancer, showing that real support ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results